• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GNV
Click for more information
0.00% 2.6¢

GREEN INVEST LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
GNV
Ann: Meeting Requisition 		05/02/16 0 466
05/02/16 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  466 
GNV
Ann: Suspension from Official Quotation - Annual Listing Fees 		25/08/15 0 553
25/08/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  553 
GNV
Ann: GPUSA - Business Update 		31/07/15 1 797
31/07/15 Last post  vintage Comments Created with Sketch.  1  Views Created with Sketch.  797 
CFU +
Ann: Suspension from Official Quotation 		02/03/15 0 1.3K
02/03/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.3K 
GNV
Ann: Substantial Holder Notices 		05/02/15 0 514
05/02/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  514 
GNV
Ann: Appendix 3Y 		30/01/15 0 394
30/01/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  394 
GNV
Ann: Appendix 3Y 		30/01/15 0 307
30/01/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  307 
GNV
Ann: Appendix 3B 		28/01/15 0 339
28/01/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  339 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.